PLASMAPHERESIS IN PATIENT WITH GUILLAIN-BARRE SYNDROME OF THE INTENSIVE CARE UNIT
DOI:
https://doi.org/10.47604/jhmn.1165Keywords:
Guillain-Barre Syndrome, Intensive Care, PlasmapheresisAbstract
Purpose: The purpose of writing this case report is to determine the importance of patient treatment using appropriate and specific therapies and the use of mechanical ventilation in the threat of respiratory failure of patients with GBS.
Methodology: We presented a case of 47 years old man with chief complaint of weakness in both upper and lower extremities. The patient was diagnosed with GBS and plasmapheresis was performed.
Findings: Holistic intensive care together with plasmapheresis has been shown to improve the survival of patients with GBS. In the current study, the patient was admitted for 1 day in HCU before he experienced difficulty in breathing, was intubated, and transferred to ICU. Plasmapheresis was performed six times in the ICU. The patient progressively improved until he was discharged to the HCU on 10th day of ICU admission.
Unique contribution to theory, practice, and policy: Holistic intensive care together with plasmapheresis has been shown to improve the survival of patients with GBS. From the current study, we recommend healthcare practitioners to perform either IVIG therapy or plasmapheresis for GBS patient
Downloads
References
2. Verboon, C., van Doorn, P. A., & Jacobs, B. C. (2017). Treatment dilemmas in Guillain-Barré syndrome. Journal of Neurology, Neurosurgery & Psychiatry, 88(4), 346-352.
3. Bhagat, H., Dash, H. H., Chauhan, R. S., Khanna, P., & Bithal, P. K. (2014). Intensive care management of Guillain-Barre syndrome: a retrospective outcome study and review of literature. Journal of Neuroanaesthesiology and Critical Care, 1(03), 188-197.
4. Kishore, C.K., Vijayabhaskar, J., Vardhan, R. V., Sainaresh, V.V., Siramnaveen, P., Sridhar, A.V.S.S.N., … & Kumar, S. (2014). Management of FUillan-Barre syndrome with plasmapheresis or immunoglobulin: our experience from a tertiary care institute in South India. Renal Failure, 36(5), 732-736.
5. McGrogan, A., Madle, G. C., Seaman, H. E., & De Vries, C. S. (2009). The epidemiology of Guillain-Barré syndrome worldwide. Neuroepidemiology, 32(2), 150-163.
6. González, P., García, X., Guerra, A., Arango, J. C., Delgado, H., Uribe, C. S., ... & Hernández, O. (2016). Experience with Guillain-Barré syndrome in a neurological intensive care unit. Neurología (English Edition), 31(6), 389-394.
7. Joshi, K., Patel, M., Gupta, R. & Bajaj, N. (2016) Guillain–barre syndrome: a case report. Int J Med Sci Public Health, 5,1295–1296.
8. Dharmayanti, A., & Astrawinata, D. (2017). Ventilator-Associated Pneumonia (VAP) in a Patient with Guillain-Barre Syndrome. Acta Medica Indonesiana, 49(2), 151-157.
9. Meena, A. K., Khadilkar, S. V., & Murthy, J. M. K. (2011). Treatment guidelines for Guillain–Barré syndrome. Annals of Indian Academy of Neurology, 14(Suppl1), S73.
10. Van Doorn, P. A., Ruts, L., & Jacobs, B. C. (2008). Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. The Lancet Neurology, 7(10), 939-950.
11. Fridey, J.L. (2017) Therapeutic apheresis (Plasma exchange or cytapheresis): indcation and technology. JA Silvergleid eds.
Downloads
Published
How to Cite
Issue
Section
License
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
